Search Results

There are 1118 results for: content related to: Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma

  1. Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat

    European Journal of Neuroscience

    Volume 23, Issue 7, April 2006, Pages: 1757–1765, Thomas Freret, Samuel Valable, Laurent Chazalviel, Romaric Saulnier, Eric T. Mackenzie, Edwige Petit, Myriam Bernaudin, Michel Boulouard and Pascale Schumann-Bard

    Article first published online : 5 APR 2006, DOI: 10.1111/j.1460-9568.2006.04699.x

  2. You have free access to this content
    The superoxide dismutase activity of desulfoferrodoxin from Desulfovibrio desulfuricans ATCC 27774

    European Journal of Biochemistry

    Volume 261, Issue 2, April (II) 1999, Pages: 438–443, Célia V. Romão, Ming Y. Liu, Jean Le Gall, Cláudio M. Gomes, Vera Braga, Isabel Pacheco, António V. Xavier and Miguel Teixeira

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00278.x

  3. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization

    British Journal of Haematology

    Volume 170, Issue 6, September 2015, Pages: 874–883, Evangelia Vlachodimitropoulou Koumoutsea, Maciej Garbowski and John Porter

    Article first published online : 1 JUN 2015, DOI: 10.1111/bjh.13512

  4. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload

    European Journal of Haematology

    Volume 88, Issue 5, May 2012, Pages: 431–438, Yesim Aydinok, Sule Unal, Yesim Oymak, Canan Vergin, Zeynep D. Türker, Dilek Yildiz and Akif Yesilipek

    Article first published online : 7 MAR 2012, DOI: 10.1111/j.1600-0609.2012.01769.x

  5. You have free access to this content
    Desulfoferrodoxin of Clostridium acetobutylicum functions as a superoxide reductase

    FEBS Letters

    Volume 581, Issue 29, December 11, 2007, Pages: 5605–5610, Oliver Riebe, Ralf-Jörg Fischer and Hubert Bahl

    Article first published online : 19 NOV 2007, DOI: 10.1016/j.febslet.2007.11.008

  6. The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells

    British Journal of Haematology

    Volume 170, Issue 2, July 2015, Pages: 236–246, Tiziana Tataranni, Francesca Agriesti, Carmela Mazzoccoli, Vitalba Ruggieri, Rosella Scrima, Ilaria Laurenzana, Fiorella D'Auria, Franca Falzetti, Mauro Di Ianni, Pellegrino Musto, Nazzareno Capitanio and Claudia Piccoli

    Article first published online : 30 MAR 2015, DOI: 10.1111/bjh.13381

  7. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia


    Volume 54, Issue 6, June 2014, Pages: 1542–1551, June-Won Cheong, Hyeoung-Joon Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, Jae Hoon Lee, Hee-Sook Park, Ho Young Kim, Hyeok Shim, Chu-Myung Seong, Chul Soo Kim, Jooseop Chung, Myung Soo Hyun, Deog-Yeon Jo, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, Byung Soo Kim, Young-Don Joo, Chi-Young Park, Yoo Hong Min and for the Korean Society of Hematology Acute Myeloid Leukemia/Myelodysplastic Syndrome Working Party

    Article first published online : 3 DEC 2013, DOI: 10.1111/trf.12507

  8. You have free access to this content
    Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib

    International Journal of Cancer

    Volume 133, Issue 7, 1 October 2013, Pages: 1732–1742, Christophe Louandre, Zakaria Ezzoukhry, Corinne Godin, Jean-Claude Barbare, Jean-Claude Mazière, Bruno Chauffert and Antoine Galmiche

    Article first published online : 8 APR 2013, DOI: 10.1002/ijc.28159

  9. Determination of deferasirox plasma concentrations: do gender, physical and genetic differences affect chelation efficacy?

    European Journal of Haematology

    Volume 94, Issue 4, April 2015, Pages: 310–317, Francesca Mattioli, Matteo Puntoni, Valeria Marini, Carmen Fucile, Giulia Milano, Luigi Robbiano, Silverio Perrotta, Valeria Pinto, Antonietta Martelli and Gian Luca Forni

    Article first published online : 17 SEP 2014, DOI: 10.1111/ejh.12419

  10. Superoxide Reductases

    European Journal of Inorganic Chemistry

    Volume 2007, Issue 18, June 2007, Pages: 2569–2581, Alice S. Pereira, Pedro Tavares, Filipe Folgosa, Rui M. Almeida, Isabel Moura and José J. G. Moura

    Article first published online : 23 MAY 2007, DOI: 10.1002/ejic.200700008

  11. You have free access to this content
    p66Shc/Notch-3 Interplay Controls Self-Renewal and Hypoxia Survival in Human Stem/Progenitor Cells of the Mammary Gland Expanded In Vitro as Mammospheres


    Volume 25, Issue 3, March 2007, Pages: 807–815, Pasquale Sansone, Gianluca Storci, Catia Giovannini, Silvia Pandolfi, Simona Pianetti, Mario Taffurelli, Donatella Santini, Claudio Ceccarelli, Pasquale Chieco and Massimiliano Bonafé

    Article first published online : 7 DEC 2006, DOI: 10.1634/stemcells.2006-0442

  12. Possible involvement of cathepsin B/D and caspase-3 in deferoxamine-related neuroprotection of early brain injury after subarachnoid haemorrhage in rats

    Neuropathology and Applied Neurobiology

    Volume 40, Issue 3, April 2014, Pages: 270–283, Z-Q. Yu, Y. Jia and G. Chen

    Article first published online : 13 MAR 2014, DOI: 10.1111/nan.12091

  13. You have free access to this content
    Corneal epithelial nuclear ferritin: Developmental regulation of ferritin and its nuclear transporter ferritoid

    Developmental Dynamics

    Volume 237, Issue 9, September 2008, Pages: 2529–2541, Kelly E. Beazley, Maria Nurminskaya, Christopher J. Talbot and Thomas F. Linsenmayer

    Article first published online : 26 AUG 2008, DOI: 10.1002/dvdy.21691

  14. The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study

    Pediatric Blood & Cancer

    Volume 62, Issue 9, September 2015, Pages: 1592–1596, Sidharth Totadri, Deepak Bansal, Prateek Bhatia, Savita V. Attri, Amita Trehan and R. K. Marwaha

    Article first published online : 28 MAR 2015, DOI: 10.1002/pbc.25533

  15. The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia

    British Journal of Haematology

    Volume 168, Issue 4, February 2015, Pages: 576–582, Ashish Banerjee, Nicole A. Mifsud, Robert Bird, Cecily Forsyth, Jeff Szer, Constantine Tam, Sybil Kellner, Andrew Grigg, Penelope Motum, Mark Bentley, Stephen Opat and George Grigoriadis

    Article first published online : 1 OCT 2014, DOI: 10.1111/bjh.13151

  16. Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1176–1182, Weng-Foung Huang, Hsin-Chun Chou, Yi-Wen Tsai and Fei-Yuan Hsiao

    Article first published online : 19 JUN 2014, DOI: 10.1002/pds.3657

  17. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients

    European Journal of Haematology

    Volume 95, Issue 5, November 2015, Pages: 411–420, Mohsen S. Elalfy, Amira M Adly, Yasser Wali, Samir Tony, Ahmad Samir and Yasmine I. Elhenawy

    Article first published online : 27 MAR 2015, DOI: 10.1111/ejh.12507

  18. Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase

    European Journal of Haematology

    Roberto Latagliata, Chiara Montagna, Raffaele Porrini, Ambra Di Veroli, Sabrina Crescenzi Leonetti, Pasquale Niscola, Fabrizio Ciccone, Antonio Spadea, Massimo Breccia, Luca Maurillo, Angela Rago, Francesca Spirito, Michele Cedrone, Marianna De Muro, Marco Montanaro, Alessandro Andriani, Antonino Bagnato, Enrico Montefusco and Giuliana Alimena

    Article first published online : 18 SEP 2015, DOI: 10.1111/ejh.12674

  19. PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2

    Journal of Cellular Physiology

    Volume 222, Issue 3, March 2010, Pages: 635–639, Mun-Kit Choy, Mehregan Movassagh, Martin R. Bennett and Roger S.-Y. Foo

    Article first published online : 30 NOV 2009, DOI: 10.1002/jcp.21980

  20. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload


    Volume 55, Issue 7, July 2015, Pages: 1613–1620, Il-Hwan Kim, Joon-Ho Moon, Sung-Nam Lim, Sang-Kyun Sohn, Hoon-Gu Kim, Gyeong-Won Lee, Yang-Soo Kim, Ho-Sup Lee, Ki-Young Kwon, Sung-Hyun Kim, Kyung-Tae Park, Joo-Seop Chung, Won-Sik Lee, Sang-Min Lee, Myung-Soo Hyun, Hawk Kim, Hun-Mo Ryoo, Sung-Hwa Bae and Young-Don Joo

    Article first published online : 11 MAR 2015, DOI: 10.1111/trf.13036